联邦制药(03933)发盈喜 预计中期净溢利约为14.5亿元
联邦制药(03933)发布公告，预期集团截至2024年6月30日止六个月的净溢利约为人民币14.5亿元，而截至2023年6月30日止六个月净溢利约为人民币12.84亿元。
净溢利上升主要受惠于：(1)中间体产品收入增加及生产成本持续降低，带动毛利增长约人民币1.3亿元;及(2)销售及分销开支减少约2.6亿元，抵消研发成本支出增加约人民币1亿元。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.